Bausch Health Companies (BHC) Total Liabilities (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Total Liabilities came in at $25.6 billion in Q1 2026, down 4.05% year-on-year from $26.7 billion in Q1 2025, and down 1.57% quarter-over-quarter from $26.0 billion in Q4 2025.
Bausch Health Companies (BHC) Total Liabilities (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Total Liabilities across 18 years of filings, most recently posting $25.6 billion for Q1 2026.
- Total Liabilities for Q1 2026 came in at $25.6 billion, down 4.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.6 billion (down 4.05% YoY), and the FY2025 annual result was $26.0 billion, down 3.19% from the prior year.
- Total Liabilities came in at $25.6 billion for Q1 2026 at Bausch Health Companies, down from $26.0 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $29.2 billion in Q1 2022 to a low of $25.2 billion in Q2 2023.
- The 5-year median for Total Liabilities is $26.7 billion (2024), against an average of $26.6 billion.
- Peak annual rise in Total Liabilities reached 7.89% in 2023, while the deepest fall reached 13.45% in 2023.
- Bausch Health Companies' Total Liabilities stood at $25.4 billion in 2022, then rose by 7.89% to $27.4 billion in 2023, then slipped by 2.14% to $26.8 billion in 2024, then decreased by 3.19% to $26.0 billion in 2025, then dropped by 1.57% to $25.6 billion in 2026.
- The last three Total Liabilities figures came in at $25.6 billion (Q1 2026), $26.0 billion (Q4 2025), and $26.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 31.81 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.92 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 813.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 148.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.50 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.72 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.82 Bn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | 25.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.58 Bn |
| Dec 31, 2025 | 25.99 Bn |
| Sep 30, 2025 | 26.47 Bn |
| Jun 30, 2025 | 27.12 Bn |
| Mar 31, 2025 | 26.66 Bn |
| Dec 31, 2024 | 26.85 Bn |
| Sep 30, 2024 | 26.78 Bn |
| Jun 30, 2024 | 26.72 Bn |
| Mar 31, 2024 | 27.09 Bn |
| Dec 31, 2023 | 27.43 Bn |
| Sep 30, 2023 | 27.30 Bn |
| Jun 30, 2023 | 25.23 Bn |
| Mar 31, 2023 | 25.30 Bn |
| Dec 31, 2022 | 25.43 Bn |
| Sep 30, 2022 | 25.87 Bn |
| Jun 30, 2022 | 27.92 Bn |
| Mar 31, 2022 | 29.23 Bn |
| Dec 31, 2021 | 29.24 Bn |
| Sep 30, 2021 | 29.39 Bn |
| Jun 30, 2021 | 30.65 Bn |